These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Evaluation of the effect of a plant alkaloid (berberine derived from Berberis aristata) on Trichomonas vaginalis in vitro. Soffar SA; Metwali DM; Abdel-Aziz SS; el-Wakil HS; Saad GA J Egypt Soc Parasitol; 2001 Dec; 31(3):893-904 + 1p plate. PubMed ID: 11775115 [TBL] [Abstract][Full Text] [Related]
8. Treatment of metronidazole-resistant Trichomonas vaginalis. Goldman LM; Upcroft JA; Workowski K; Rapkin A Sex Health; 2009 Dec; 6(4):345-7. PubMed ID: 19917205 [TBL] [Abstract][Full Text] [Related]
9. Resistance of Trichomonas vaginalis infections to metronidazole in Auckland sexual health clinics: report of two cases. Lo M; Reid M; Brokenshire M N Z Med J; 2002 Aug; 115(1160):U147. PubMed ID: 12362204 [No Abstract] [Full Text] [Related]
10. Paromomycin for nitroimidazole-resistant trichomonosis. Nyirjesy P; Weitz MV; Gelone SP; Fekete T Lancet; 1995 Oct; 346(8982):1110. PubMed ID: 7564825 [No Abstract] [Full Text] [Related]
11. Nitroimidazole Resistance in Trichomonas vaginalis Infection: A Teachable Moment. Salas A; Hamill MM; Tuddenham S JAMA Intern Med; 2019 Feb; 179(2):247-248. PubMed ID: 30575848 [No Abstract] [Full Text] [Related]
12. Alternative drugs against Trichomonas vaginalis. Mahdi NK; Gany ZH; Sharief M East Mediterr Health J; 2006 Sep; 12(5):679-84. PubMed ID: 17333809 [TBL] [Abstract][Full Text] [Related]
14. [Studies on the velocity of action of trichomonocidal drugs]. Broccali G; De Carneri I Ginecol Obstet Mex; 1971 Nov; 30(181):481-90. PubMed ID: 5316160 [No Abstract] [Full Text] [Related]
15. [Treatment of trichomonas infections with tinidazol in women]. Diwald J Wien Med Wochenschr; 1971 Jun; 121(24):492-4. PubMed ID: 5315293 [No Abstract] [Full Text] [Related]
16. Comparative in vitro cytotoxic effects of ornidazole, metronidazole and ciprofloxacin against Trichomonas vaginalis trophozoites. Inceboz T; Inceboz U; Ozturk S J Chemother; 2004 Oct; 16(5):459-62. PubMed ID: 15565912 [TBL] [Abstract][Full Text] [Related]
17. Recalcitrant Trichomonas vaginalis infection--a case series. Waters LJ; Dave SS; Deayton JR; French PD Int J STD AIDS; 2005 Jul; 16(7):505-9. PubMed ID: 16004634 [TBL] [Abstract][Full Text] [Related]
18. Synthesis and antiprotozoan properties of new 3,5-disubstituted-tetrahydro-2H-1,3,5-thiadiazine-2-thione derivatives. Ochoa C; Pérez E; Pérez R; Suárez M; Ochoa E; Rodríguez H; Gómez Barrio A; Muelas S; Nogal JJ; Martínez RA Arzneimittelforschung; 1999 Sep; 49(9):764-9. PubMed ID: 10514905 [TBL] [Abstract][Full Text] [Related]
19. [Characteristics of the action of nitrimidazine (nimorazol), a new systemic trichomonacidal agent. I. Microbiological study]. De Carneri I; Cantone A; Emanueli A; Giraldi PN; Logemann W; Longo R; Meinardi G; Monti G; Nannini G; Tosolini G; Trane F; Vita G Boll Chim Farm; 1972 Jul; 111(7):393-408. PubMed ID: 4538708 [No Abstract] [Full Text] [Related]
20. Novel metronidazole-chalcone conjugates with potential to counter drug resistance in Trichomonas vaginalis. Anthwal A; Rajesh UC; Rawat MS; Kushwaha B; Maikhuri JP; Sharma VL; Gupta G; Rawat DS Eur J Med Chem; 2014 May; 79():89-94. PubMed ID: 24727243 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]